Norwest & Rouse Hill (02) 8530 1800 Pennant Hills (02) 9875 2311 Macquarie Park (02) 9812 3880
A/Prof Viraj KariyawasamGastroenterologist · Sydney

Home › Services › Sessile serrated polyps

Condition

Sessile serrated polyps and the serrated pathway

If a colonoscopy report says a sessile serrated lesion was removed, it means a flat polyp with the potential to become cancer has been taken out before it did. The lesion itself was not cancer. A/Prof Kariyawasam has a particular research interest in serrated polyps and the serrated pathway, and performs colonoscopy and endoscopic mucosal resection at Norwest Private Hospital, Macquarie University Hospital and Pennant Hills Day Surgery.

What it isA flat, pale polyp, usually in the right side of the colon, that can slowly turn into bowel cancer if it is left alone.
Why it mattersBetween 15 and 30 per cent of bowel cancers are now thought to begin as a serrated lesion rather than as an ordinary adenoma.
How it is foundRecognised at colonoscopy by its appearance, then confirmed by the pathologist.
When there are manyEnough of them, counted across all your colonoscopies, means serrated polyposis syndrome.

What a sessile serrated lesion actually is

Most people picture a polyp as a small cherry on a stalk. Serrated lesions are not like that. "Sessile" means flat against the bowel wall rather than raised on a stalk, and the lesions are usually pale rather than red, with borders that fade into the surrounding lining rather than standing out from it. Many are covered by a cap of mucus, and in about half of them a rim of bubbles or debris sits over the surface, which is one of the things an endoscopist looks for.

"Serrated" describes what the pathologist sees under the microscope. The glands in the bowel lining have a sawtooth outline instead of the neat round profile of normal lining. That is what the diagnosis rests on, though it is not the only way these lesions are identified: they have their own appearance at colonoscopy too, covered below.

The naming has changed more than once, which is why reports from different years read differently. These lesions were called sessile serrated adenomas, then sessile serrated adenomas or polyps, and since the World Health Organization's 2019 classification the agreed term has been sessile serrated lesion, with or without dysplasia. Two things drove the change. Most of these lesions do not contain true dysplasia, so the word adenoma implied something the pathology did not show. And many are flat rather than polypoid, so the word polyp did not fit either. A report using any of the older names is describing the same thing.

Serrated polyps are a family rather than a single lesion. The 2019 classification lists four categories: hyperplastic polyps, which are the commonest and, when small and in the rectum or sigmoid, are not thought to be markers of future bowel cancer risk; sessile serrated lesions, with or without dysplasia; traditional serrated adenomas, which are uncommon; and a small unclassified group. Sessile serrated lesions with dysplasia and traditional serrated adenomas are the ones most often found to be the precursor when a cancer develops by this route.

How serrated polyps differ from ordinary adenomas

There is more than one route from normal bowel lining to bowel cancer. The familiar one runs through conventional adenomas, accumulating mutations as it goes, with a gene called APC usually switched off early. The serrated route works differently. It is set off instead by a mutation in one of two genes that carry cell growth signals, BRAF or KRAS, and which of the two is involved marks out two separate pathways. From there it progresses mainly by switching tumour suppressor genes off without altering the DNA sequence at all, a process called methylation. The pattern this produces is known as the CpG island methylator phenotype, and it is regarded as the main engine of the serrated route to cancer.

This matters practically, because the cancer at the end of it is a different kind of cancer. One of its characteristic features is a fault in the cell's mismatch repair system, the machinery that proofreads DNA as it copies. A/Prof Kariyawasam's group examined that link directly in a review of more than 109,000 histopathology requests from a large New South Wales laboratory, presented at Australian Gastroenterology Week in 2026. Serrated lesions carried about three times the odds of showing a mismatch repair fault once the other factors were allowed for, which puts the serrated pathway among the main contributors to that type of bowel cancer.

Between 15 and 30 per cent of bowel cancers are now thought to arise through the serrated pathway rather than the adenoma pathway, which is why a lesion type once thought harmless is now removed and followed.

Can they be recognised at colonoscopy?

Yes. A sessile serrated lesion has its own appearance, and an endoscopist who knows the features can usually identify one at the time rather than waiting to be told by the laboratory. The pathology report confirms the diagnosis and says whether there is dysplasia, but the recognition happens during the procedure, which is what allows the lesion to be removed properly on the spot.

The features that mark one out are a flat or only slightly raised profile, a pale colour against the surrounding lining, borders that fade rather than stand out, and a resemblance to a prominent fold rather than to a lump. A cap of mucus over the surface is characteristic, and in just over half of these lesions a rim of bubbles or debris sits on top, which is one of the more reliable pointers. On the electronic enhancement most modern scopes carry, the surface has a cloud-like look, an irregular outline and dark spots inside the glands. Under magnification the pattern of the gland openings is a distinct one, open and rounded rather than the star shape seen in hyperplastic polyps, and studies of that pattern alone report sensitivity for identifying a sessile serrated lesion of 84 to 97 per cent.

These features have been put into a formal system, the WASP classification, built for exactly this problem because the earlier systems did not include sessile serrated lesions at all. In the study that developed and tested it, ten consultant gastroenterologists classified polyps before and after being trained in it, and the accuracy of their endoscopic diagnosis rose from 63 to 79 per cent, and to 87 per cent for the lesions they were confident about. Six months later the improvement had held. That is a worked example of the general point: these lesions are recognisable, and recognising them is a learned skill rather than a given.

Why serrated lesions are easier to overlook

Recognisable is not the same as conspicuous. A red polyp on a stalk announces itself from a distance. A pale flat lesion that looks like a slightly prominent fold has to be looked for, and the right side of the colon, where they characteristically sit, is the harder half to examine well.

The published detection figures show how much this varies in practice. In one study of 7,192 screening colonoscopies by thirteen endoscopists, sessile serrated lesions found per 100 colonoscopies ranged from none at all in the lowest detector to 2.2 in the highest. In a multicentre study across 32 centres, serrated lesion detection rates ranged from zero to 13.1 per cent, and four centres reported no proximal serrated lesions at all over two years. That spread is not explained by the patients.

Because of it, detection of these lesions is now measured in the same way adenoma detection has been for years. The 2026 international consensus statement sets a minimum acceptable sessile serrated lesion detection rate of 6 to 7 per cent, with an aspirational figure approaching 20 per cent, and recommends that anyone known to have serrated polyposis syndrome has their colonoscopy done by an endoscopist whose detection rate for these lesions is documented and at least 6 per cent.

Two other things follow from the same problem. Cancers that appear in the interval between colonoscopies are over-represented in the serrated pathway, which is consistent with these lesions being the ones most often missed or incompletely removed. And when a serrated lesion is taken out in pieces, the chance of some being left behind is higher than for an adenoma, which is why a check of the scar matters.

None of this is a reason for alarm about having had a colonoscopy. It is the reason the preparation instructions are strict, why a careful withdrawal takes the time it takes, and why dye spray or electronic enhancement is used to bring out the features described above. In one trial in people with serrated polyposis syndrome, extra sessile serrated lesions were found in 21.6 per cent of patients examined with white light alone, 39.1 per cent with an added dye spray, and 63.4 per cent with dye spray plus acetic acid.

How common are they?

More common than most people expect. Across five European screening cohorts, serrated polyps of some kind were found in between 15.1 and 27.2 per cent of people examined, with a median of 19.5 per cent, so roughly one in five. Sessile serrated lesions specifically were found in 2.2 to 4.8 per cent, with a median of 3.3 per cent. That analysis found no apparent association between the rate of serrated polyps and age or sex.

Serrated polyposis syndrome, the diagnosis made when there are many of them, is estimated at around one person in 250 having a screening colonoscopy, and is commoner again among people having colonoscopy after a positive stool test, where European studies have put it as high as one in 111. It is the commonest polyposis syndrome of the bowel, and more common than all the other gastrointestinal polyposis syndromes put together. It is also, on the evidence of several studies, substantially underdiagnosed, which is unsurprising given that the counts defining it add up across colonoscopies rather than within one.

What the Australian data shows

A/Prof Kariyawasam is senior author on a study of what is actually being found in Australian practice, presented at Australian Gastroenterology Week in 2026. It reviewed every colonic histopathology report from a large independent New South Wales laboratory between 2012 and 2025, covering 109,701 requests and 236,338 samples, almost all from New South Wales. Sessile serrated lesions made up 11.9 per cent of the samples, against 42.8 per cent conventional adenomas.

Three findings from it are worth knowing.

Right-sided, strongly

Samples from the right colon were far more likely to contain a sessile serrated lesion than samples from the left, and the association was stronger for serrated lesions than for other significant lesions. That is the quantified version of why careful examination of the right colon matters so much for this particular lesion.

Rising

Detection of sessile serrated lesions increased year on year across the fourteen years of the dataset. What that study cannot tell you is how much of the rise is more lesions and how much is better recognition and reporting, since the same years saw the terminology settle and awareness grow. Both are probably contributing, and the honest position is that the split is not yet known.

Younger and female

This is the finding that runs against expectation. For bowel lesions overall, the familiar pattern holds: the older you are, the more likely something is found. Serrated lesions behave the opposite way. Older age and male sex were both associated with lower detection of sessile serrated lesions, and people under 45 carried roughly five times the odds of a serrated lesion being found compared with people 45 and over, even though their detection of significant bowel lesions overall was lower. Dysplasia was uncommon, and no commoner on one side of the colon than the other.

Two caveats belong with this. The study counts what laboratories received, so it reflects both what is present in people's bowels and what endoscopists found and sent, which is a different thing from the rate in the general population. And it has been presented as a conference abstract rather than published as a full paper. What it supports, and supports well, is the practical conclusion the authors drew: the right colon warrants meticulous inspection, serrated lesion recognition matters, and younger adults, particularly younger women, are a group in whom these lesions should be actively looked for rather than assumed to be unlikely.

Does a sessile serrated lesion mean cancer?

No. A sessile serrated lesion is a precancerous lesion, which means it has the potential to become cancer over years, not that it is cancer or is about to be. Cancer is in fact found far less often in a sessile serrated lesion than in a conventional adenoma of the same size.

What raises concern within the group is size and dysplasia. A lesion of 10 mm or more, or one the pathologist reports as containing dysplasia, or a traditional serrated adenoma, sits in a higher risk group and is followed more closely. Small hyperplastic polyps in the rectum and sigmoid are at the other end and are not thought to be markers of future bowel cancer risk.

One finding worth knowing, because it explains why follow-up is advised even after a single lesion: in a retrospective study, 15 per cent of people who had a sessile serrated lesion at their first colonoscopy went on to have an advanced lesion over an average of 8.3 years. One serrated lesion makes a second one more likely, which points to a change across the lining rather than a single isolated spot.

How are they removed?

Most are removed during the same colonoscopy that finds them, with a snare, and nothing more is needed. These lesions are usually taken off cold, meaning without electrocautery, which for serrated lesions is effective at any size and carries fewer complications. Larger and flatter lesions need endoscopic mucosal resection, which means lifting the lesion away from the bowel wall with an injection underneath it and then taking it off in one piece or in several. Where dysplasia is visible at the time, the approach changes and cautery is generally used. A/Prof Kariyawasam performs endoscopic mucosal resection of colonic polyps. Lesions better suited to endoscopic submucosal dissection are referred to a colleague who performs that technique, and he stays involved in the follow-up.

Where a lesion of 20 mm or more has been taken out in pieces, the site is checked at two to six months rather than waiting for the next full surveillance colonoscopy. Australian data on piecemeal resection of serrated lesions of 20 mm or more found a recurrence rate of 7 per cent at twelve months, against 20 per cent for adenomas, so lower than for adenomas but not low enough to skip the check. For lesions between 10 and 20 mm removed in pieces, whether a site check is needed is a judgement made at the time.

When is the next colonoscopy?

That depends on how many lesions were found, how big they were and what the pathology showed, and it is set by guideline rather than by preference. The Australian intervals, and how they compare with the British, European and American ones, are set out in full on the surveillance colonoscopy intervals page.

In outline, under the Australian guideline, one or two serrated polyps with none of them advanced means five years, and three years if one is advanced. Three or four means three years, or one year if one is advanced. Five or more means one year. An advanced serrated polyp here means a sessile serrated lesion of 10 mm or more, one containing dysplasia, or a traditional serrated adenoma. Where adenomas were found at the same time, the counting combines the two and the intervals shorten.

The British position statement puts it slightly differently and is useful for the two ends of the range. It suggests a single surveillance colonoscopy at three years for a sessile serrated lesion of 10 mm or more, or any serrated lesion containing dysplasia including a traditional serrated adenoma. For hyperplastic polyps or sessile serrated lesions under 10 mm without dysplasia, it finds no clear indication for surveillance at all, unless the number, size and location add up to serrated polyposis syndrome.

Complete removal has to be confirmed before any interval can be set. An interval quoted before the pathology is back is provisional.

When there are many: serrated polyposis syndrome

A few serrated polyps is an ordinary finding. Enough of them is a diagnosis in its own right, called serrated polyposis syndrome, and it changes both the follow-up and what is advised for close relatives.

It is defined by counting rather than by a blood test, and the counts run across every colonoscopy a person has had rather than within one of them. The World Health Organization definition, set in 2019, is met by either five or more serrated polyps above the rectum, all 5 mm or larger with at least two of them 10 mm or larger, or more than 20 serrated polyps anywhere in the large bowel with at least five above the rectum.

That cumulative counting is the single most useful thing to know about it, and the commonest reason it is missed. Someone with four serrated polyps on one occasion and three on another meets the first pattern if the sizes fit, even though neither report looked alarming. It is the commonest polyposis syndrome of the bowel, found in roughly one person in 250 having a screening colonoscopy, and it is substantially underdiagnosed.

It does raise bowel cancer risk, and the shape of that risk is more reassuring than the headline number suggests: most of it is cancer already present when the syndrome is first recognised rather than cancer arising during follow-up. It is managed by clearing the polyps at colonoscopy and keeping ahead of them. Surgery is the exception.

If this applies to you, or you are not sure whether it does, there is a full page on it. Serrated polyposis syndrome covers the criteria, what the cancer risk actually means, the clearing and surveillance phases, what it means for family and why genetic testing is usually not needed.

What raises the risk, and what seems to lower it

A systematic review of 43 studies looked at lifestyle factors and serrated polyps specifically, comparing the highest and lowest categories of exposure. Smoking stood out, with a relative risk of 2.47 and a 95 per cent confidence interval of 2.12 to 2.87. Alcohol intake came to 1.33, and body mass index to 1.40. High intake of fat or meat also raised risk. The associations with smoking and alcohol were stronger for sessile serrated lesions than for hyperplastic polyps, which fits the lesion that matters most being the one most affected.

On the other side, high intake of folate, calcium or fibre was associated with lower risk, as was regular use of anti-inflammatory painkillers and aspirin. For people with serrated polyposis syndrome specifically, Australian patient information notes that daily aspirin is sometimes recommended to reduce bowel cancer risk. That is a conversation to have with your doctor rather than something to start on your own, since aspirin carries its own risks.

Smoking deserves a paragraph of its own, because the picture is more complicated than it first looks. The association with serrated polyps is the strongest of any modifiable factor, and the link with serrated polyposis syndrome is strong too. But plenty of people with the syndrome have never smoked, and there is at present no evidence that stopping changes the course of the syndrome once it is established. Stopping remains worth doing, for the risk of further polyps and for every other reason, and it should not be framed as the cause in someone who never smoked.

Getting the most out of the appointment

Bring the colonoscopy report and the pathology report if you have them, and the reports from any earlier colonoscopies. For serrated lesions the earlier reports are not a formality: the counting that defines serrated polyposis syndrome adds up across examinations, so a run of reports can change the diagnosis where any single one would not.

Worth knowing before you come:

  • how many polyps were removed, where they were and how big the largest was
  • whether the pathology said hyperplastic polyp, sessile serrated lesion or traditional serrated adenoma, and whether dysplasia was mentioned
  • whether anything was removed in pieces
  • whether anyone in the family has had bowel cancer or bowel polyps, and at what age
  • whether you smoke, and whether you would like help stopping

Common questions

The questions people actually ask, answered plainly.

How did the endoscopist know it was a serrated polyp before the pathology came back?

Because these lesions have a distinct appearance. Flat profile, pale colour, indistinct borders, a look closer to a prominent fold than a lump, a cap of mucus, and often a rim of bubbles sitting on the surface. With electronic enhancement the surface has a cloud-like texture and dark spots inside the glands, and under magnification the gland openings form a pattern different from that of a hyperplastic polyp. A formal system exists for making the call at the time, and training in it has been shown to improve accuracy. The pathology confirms the diagnosis and reports whether dysplasia is present, so the two work together rather than one replacing the other.

Is a sessile serrated lesion the same as a sessile serrated adenoma?

Yes. The name has changed, the lesion has not. These were called sessile serrated adenomas, then sessile serrated adenomas or polyps, and since 2019 the agreed term has been sessile serrated lesion, with or without dysplasia. The word adenoma was dropped because most of these lesions do not contain true dysplasia, and the word polyp because many of them are flat rather than polypoid. Reports from different years and different laboratories may use any of the three.

Are serrated polyps cancer?

No. A sessile serrated lesion is precancerous, which means it has the potential to become cancer over years if it is left alone. Removing it closes that off, and cancer is found far less often in one of these lesions than in a conventional adenoma of the same size. Size and pathology decide how closely things are followed afterwards: a lesion of 10 mm or more, one containing dysplasia, or a traditional serrated adenoma sits in a higher risk group than a small lesion without dysplasia.

My report says hyperplastic polyp. Is that the same thing?

It is in the same family and it is not the same thing. Hyperplastic polyps are the commonest serrated polyp, and small ones in the rectum and sigmoid are not considered a bowel cancer risk. They start to matter when they are large, when they sit in the right side of the colon, or when there are enough of them to meet the criteria for serrated polyposis syndrome. Telling a hyperplastic polyp from a sessile serrated lesion under the microscope also gets harder the smaller the lesion is, which is one reason the same polyp can be reported differently by different laboratories.

Why was my polyp removed in pieces, and why do I need a check at six months?

A flat lesion spread across the bowel wall sometimes cannot be taken off in one piece safely. Removing it in pieces works, but it leaves more chance that a fragment remains, and the evidence shows that chance is higher for serrated lesions than for adenomas. For lesions of 20 mm or more the scar is therefore checked at two to six months. Australian data put recurrence at 7 per cent at twelve months for serrated lesions of that size, against 20 per cent for adenomas, so the check usually confirms the site is clear.

I had a clear stool test last year. How did I still have a polyp?

The stool test in the National Bowel Cancer Screening Program looks for blood, and polyps often do not bleed, serrated ones least of all. A negative test means no blood was found in that sample, not that there is nothing there. This is a known limitation rather than a failure, and it is why symptoms or a family history are assessed on their own merits rather than being settled by a clear stool test.

How many serrated polyps are too many?

The threshold is five or more above the rectum, all 5 mm or larger with at least two of them 10 mm or larger, or more than 20 anywhere in the large bowel with at least five above the rectum. Past that it is called serrated polyposis syndrome. The counts add up across colonoscopies, not within one, so it is worth having all the past reports looked at together. Coming close without reaching the threshold is not a discharge either: people in that position carry some increased risk and are followed accordingly.

Should my children be screened?

For a sessile serrated lesion removed on its own there is no routine recommendation to examine relatives. That changes if the numbers meet the criteria for serrated polyposis syndrome, where first-degree relatives do have a raised risk and should be offered colonoscopy rather than the stool test alone.

Will stopping smoking make a difference now?

Smoking is the strongest modifiable risk factor identified for serrated polyps, with roughly two and a half times the risk between the heaviest and lightest exposure categories in a systematic review of 43 studies, and the association is stronger for sessile serrated lesions than for hyperplastic polyps. Stopping is worth doing on its own terms, and the rooms can help arrange support.

Where these figures come from

This page is general information. It is not advice about your own situation, and it is not a substitute for seeing a doctor. If you have symptoms, see your GP.

Make an appointment

Appointments are booked through the rooms directly. Have your GP referral ready when you call or ask your GP to send it ahead. Urgent inflammatory bowel disease, rectal bleeding and positive bowel screening referrals are prioritised.

Norwest & Rouse Hill (02) 8530 1800 Pennant Hills (02) 9875 2311 Macquarie Park (02) 9812 3880